Cargando…

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy

Immunotherapy is a fast advancing methodology involving one of two approaches: (1) compounds targeting immune checkpoints and (2) cellular immunomodulators. The latter approach is still largely experimental and features in vitro generated, live immune effector cells, or antigen-presenting cells. γδ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Mohd Wajid A., Eberl, Matthias, Moser, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204533/ https://www.ncbi.nlm.nih.gov/pubmed/25374569 http://dx.doi.org/10.3389/fimmu.2014.00512

Ejemplares similares

Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions
por: Khan, Mohd Wajid A., et al.
Publicado: (2014)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Human γδ T-Cell Control of Mucosal Immunity and Inflammation
por: McCarthy, Neil E., et al.
Publicado: (2018)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells
por: Eberl, Matthias, et al.
Publicado: (2014)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Antigen-Presenting Human γδ T Cells Promote Intestinal CD4(+) T Cell Expression of IL-22 and Mucosal Release of Calprotectin
por: Tyler, Christopher J., et al.
Publicado: (2017)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8(+) T cells
por: Chen, Hung-Chang, et al.
Publicado: (2017)

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
por: Bartish, Margarita, et al.
Publicado: (2020)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

A Rapid Crosstalk of Human γδ T Cells and Monocytes Drives the Acute Inflammation in Bacterial Infections
por: Eberl, Matthias, et al.
Publicado: (2009)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2023)

γδ T cells as a potential therapeutic agent for glioblastoma
por: Kang, In, et al.
Publicado: (2023)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

Impact of BCG vaccination on the repertoire of human γδ T cell receptors
por: Xia, Mei, et al.
Publicado: (2023)

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters
por: Rhodes, David A., et al.
Publicado: (2018)

γδ T cells and their clinical application in colon cancer
por: Corsale, Anna Maria, et al.
Publicado: (2023)

Antigen recognition by human γδ T cells: one step closer to knowing
por: Eberl, Matthias
Publicado: (2020)

COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy
por: Wang, Li, et al.
Publicado: (2022)

Chronic Inflammation and γδ T Cells
por: Fay, Nathan S., et al.
Publicado: (2016)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy
por: Ferry, Gabrielle M., et al.
Publicado: (2022)

Identification of the Ligands of TCRγδ by Screening the Immune Repertoire of γδT Cells From Patients With Tuberculosis
por: Li, Yuxia, et al.
Publicado: (2019)

The Emerging Complexity of γδT17 Cells
por: McKenzie, Duncan R., et al.
Publicado: (2018)

γδ T Cells in Brain Homeostasis and Diseases
por: Park, Jang Hyun, et al.
Publicado: (2022)

γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
por: Poggi, Alessandro, et al.
Publicado: (2014)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

Immune Effects of γδ T Cells in Colorectal Cancer: A Review
por: Ma, Rulan, et al.
Publicado: (2020)

Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis
por: Liu, Bing, et al.
Publicado: (2022)

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
por: Duan, Li-Juan, et al.
Publicado: (2022)

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection
por: Khairallah, Camille, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l9tpjdvhc6g7ha3kd3ag9hb1t2